Leonid Gaidukov

4.2k total citations · 2 hit papers
24 papers, 3.1k citations indexed

About

Leonid Gaidukov is a scholar working on Molecular Biology, Clinical Biochemistry and Microbiology. According to data from OpenAlex, Leonid Gaidukov has authored 24 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Clinical Biochemistry and 7 papers in Microbiology. Recurrent topics in Leonid Gaidukov's work include Paraoxonase enzyme and polymorphisms (10 papers), Antimicrobial Peptides and Activities (7 papers) and Biochemical and Structural Characterization (5 papers). Leonid Gaidukov is often cited by papers focused on Paraoxonase enzyme and polymorphisms (10 papers), Antimicrobial Peptides and Activities (7 papers) and Biochemical and Structural Characterization (5 papers). Leonid Gaidukov collaborates with scholars based in Israel, United States and France. Leonid Gaidukov's co-authors include Dan S. Tawfik, Amir Aharoni, Olga Khersonsky, Amram Mor, Cintia Roodveldt, Lilly Toker, Israel Silman, Mira Rosenblat, Michael Aviram and Arie Dagan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Leonid Gaidukov

24 papers receiving 3.1k citations

Hit Papers

The 'evolvability' of pro... 2004 2026 2011 2018 2004 2004 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leonid Gaidukov Israel 22 1.5k 1.1k 762 574 452 24 3.1k
K.P. Battaile United States 34 2.1k 1.3× 211 0.2× 121 0.2× 94 0.2× 130 0.3× 131 3.6k
Andrew M. Gulick United States 37 3.3k 2.2× 104 0.1× 305 0.4× 206 0.4× 148 0.3× 93 4.3k
Victor Stalon Belgium 31 2.3k 1.5× 427 0.4× 221 0.3× 112 0.2× 1.1k 2.5× 80 3.3k
André Goffeau Belgium 45 5.1k 3.3× 83 0.1× 1.3k 1.7× 90 0.2× 272 0.6× 131 7.5k
Yuzuru Akamatsu Japan 25 1.4k 0.9× 108 0.1× 72 0.1× 146 0.3× 228 0.5× 90 2.5k
Martine Couturier France 33 2.2k 1.4× 183 0.2× 318 0.4× 84 0.1× 78 0.2× 97 4.5k
Charles Gilvarg United States 35 2.2k 1.4× 102 0.1× 302 0.4× 127 0.2× 413 0.9× 80 3.1k
André Pierard Belgium 34 3.2k 2.1× 375 0.3× 276 0.4× 86 0.1× 1.0k 2.2× 81 4.1k
Luiz Pedro S. de Carvalho United Kingdom 32 2.4k 1.6× 74 0.1× 127 0.2× 70 0.1× 163 0.4× 69 3.9k
W. Scott Moye‐Rowley United States 45 4.7k 3.0× 57 0.0× 1.3k 1.7× 56 0.1× 221 0.5× 103 6.8k

Countries citing papers authored by Leonid Gaidukov

Since Specialization
Citations

This map shows the geographic impact of Leonid Gaidukov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leonid Gaidukov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leonid Gaidukov more than expected).

Fields of papers citing papers by Leonid Gaidukov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leonid Gaidukov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leonid Gaidukov. The network helps show where Leonid Gaidukov may publish in the future.

Co-authorship network of co-authors of Leonid Gaidukov

This figure shows the co-authorship network connecting the top 25 collaborators of Leonid Gaidukov. A scholar is included among the top collaborators of Leonid Gaidukov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leonid Gaidukov. Leonid Gaidukov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Chien‐Wen, Leonid Gaidukov, Yong Lai, et al.. (2022). A synthetic transcription platform for programmable gene expression in mammalian cells. Nature Communications. 13(1). 6167–6167. 19 indexed citations
2.
Lewis, Nuruddeen D., Chang Ling Sia, Katherine Kirwin, et al.. (2020). Exosome Surface Display of IL12 Results in Tumor-Retained Pharmacology with Superior Potency and Limited Systemic Exposure Compared with Recombinant IL12. Molecular Cancer Therapeutics. 20(3). 523–534. 79 indexed citations
3.
Chang, Michelle, Leonid Gaidukov, Giyoung Jung, et al.. (2019). Small-molecule control of antibody N-glycosylation in engineered mammalian cells. Nature Chemical Biology. 15(7). 730–736. 55 indexed citations
4.
Gaidukov, Leonid, Liliana Wróblewska, Brian Teague, et al.. (2018). A multi-landing pad DNA integration platform for mammalian cell engineering. Nucleic Acids Research. 46(8). 4072–4086. 115 indexed citations
5.
Gaidukov, Leonid, Andrew R. Nager, Shangzhe Xu, Marsha Penman, & Monty Krieger. (2011). Glycine Dimerization Motif in the N-terminal Transmembrane Domain of the High Density Lipoprotein Receptor SR-BI Required for Normal Receptor Oligomerization and Lipid Transport. Journal of Biological Chemistry. 286(21). 18452–18464. 52 indexed citations
6.
Gaidukov, Leonid, et al.. (2009). In vivo administration of BL-3050: highly stable engineered PON1-HDL complexes. PubMed. 9(1). 18–18. 35 indexed citations
7.
Gaidukov, Leonid, et al.. (2009). ApoE Induces Serum Paraoxonase PON1 Activity and Stability Similar to ApoA-I. Biochemistry. 49(3). 532–538. 45 indexed citations
8.
Gaidukov, Leonid & Dan S. Tawfik. (2007). The development of human sera tests for HDL-bound serum PON1 and its lipolactonase activity. Journal of Lipid Research. 48(7). 1637–1646. 71 indexed citations
9.
10.
Gaidukov, Leonid, Mira Rosenblat, Michael Aviram, & Dan S. Tawfik. (2006). The 192R/Q polymorphs of serum paraoxonase PON1 differ in HDL binding, lipolactonase stimulation, and cholesterol efflux. Journal of Lipid Research. 47(11). 2492–2502. 112 indexed citations
11.
Amitai, Gabriel, Leonid Gaidukov, R. Adani, et al.. (2006). Enhanced stereoselective hydrolysis of toxic organophosphates by directly evolved variants of mammalian serum paraoxonase. FEBS Journal. 273(9). 1906–1919. 73 indexed citations
12.
Gaidukov, Leonid & Dan S. Tawfik. (2005). High Affinity, Stability, and Lactonase Activity of Serum Paraoxonase PON1 Anchored on HDL with ApoA-I. Biochemistry. 44(35). 11843–11854. 185 indexed citations
13.
Radzishevsky, Inna, Shahar Rotem, Fadia Zaknoon, et al.. (2005). Effects of Acyl versus Aminoacyl Conjugation on the Properties of Antimicrobial Peptides. Antimicrobial Agents and Chemotherapy. 49(6). 2412–2420. 85 indexed citations
14.
Harel, Michal, Amir Aharoni, Leonid Gaidukov, et al.. (2004). Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes. Nature Structural & Molecular Biology. 11(5). 412–419. 501 indexed citations breakdown →
15.
Aharoni, Amir, et al.. (2004). The 'evolvability' of promiscuous protein functions. Nature Genetics. 37(1). 73–76. 660 indexed citations breakdown →
16.
Gaidukov, Leonid, Alexander Fish, & Amram Mor. (2003). Analysis of Membrane-Binding Properties of Dermaseptin Analogues:  Relationships between Binding and Cytotoxicity. Biochemistry. 42(44). 12866–12874. 56 indexed citations
17.
18.
Kustanovich, I. M., et al.. (2002). Structural Requirements for Potent Versus Selective Cytotoxicity for Antimicrobial Dermaseptin S4 Derivatives. Journal of Biological Chemistry. 277(19). 16941–16951. 140 indexed citations
19.
Navon‐Venezia, Shiri, Rina Feder, Leonid Gaidukov, Yehuda Carmeli, & Amram Mor. (2002). Antibacterial Properties of Dermaseptin S4 Derivatives with In Vivo Activity. Antimicrobial Agents and Chemotherapy. 46(3). 689–694. 133 indexed citations
20.
Krugliak, Miriam, Rina Feder, Leonid Gaidukov, et al.. (2000). Antimalarial Activities of Dermaseptin S4 Derivatives. Antimicrobial Agents and Chemotherapy. 44(9). 2442–2451. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026